Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Internal Medicine Physician in New York, NY
NPI: 1114100047Primary Employer
Memorial Hematology Lymphoma Group
mskcc.org
HQ Phone
Get M.D. Eytan's Phone Numberphone_androidMobile
Get M.D. Eytan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2021
NJ State Medical License
2018 - 2027
NY State Medical License
2010 - 2027
CT State Medical License
2023 - 2026
NC State Medical License
2020 - 2022
IL State Medical License
2007 - 2010
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
Feinberg School of Medicine
feinberg.northwestern.edu
Medical School
Until 2007
Memorial Sloan Kettering Cancer Center
Fellowship • Hematology and Medical Oncology
2010 - 2013
McGaw Medical Center of Northwestern University
Residency • Internal Medicine
2007 - 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 140 | 548 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 59 | 59 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 55 | 76 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 51 | 79 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 21 | 92 |
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis
Does arsenic trioxide impact fertility
Authors: Martin Tallman
Publication Date: 2012-04
Authors: Todd Rosenblat, Dan Douer, Jessica Altman, Stephen Nimer, Joseph Jurcic, Rosalind Catchatourian, Hau Kwaan, Sonia Sandhu, Martin Tallman, Elizabeth Cull, Jae Park
Journal: Leuk Res
Publication Date: 2013-06-14
Lead Sponsor: GluBio Therapeutics Inc.
Intervention / Treatment: DRUG: GLB-001
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Astellas Pharma US, Inc.
Intervention / Treatment: DRUG: Enasidenib, DRUG: Gilteritinib, DRUG: Ivosidenib
Lead Sponsor: Kymera Therapeutics, Inc.
Intervention / Treatment: DRUG: KT-253